Navigation Links
Study evaluates faster treatment for seizures
Date:2/16/2012

LEXINGTON, Ky. (Feb. 16, 2012) Results have just been released from an NIH study conducted at multiple sites, including the University of Kentucky, indicating that an autoinjector pen is a faster and possibly more effective way for emergency medical personnel to treat serious seizures. The study appears in the Feb. 16, 2012 issue of The New England Journal of Medicine.

Typically, when paramedics respond to a patient with status epilepticus (a prolonged seizure lasting longer than five minutes), they attempt to start an IV to deliver anticonvulsant medication to the patient. However, starting an IV in a patient who is experiencing seizures can be challenging for paramedics and waste precious time. An autoinjector similar to the EpiPen used to treat serious allergic reactions saves time and delivers needed medication in a quick, consistent way. The autoinjector delivers medication directly into the thigh muscle as an intramuscular injection.

These results are significant, because status epilepticus is a life-threatening emergency that results in approximately 55,000 deaths in the U.S. each year.

The investigators, at UK and other institutions, compared two medicines known to be effective in controlling seizures, midazolam and lorazepam. Both are benzodiazepines, a class of sedating anticonvulsant drugs. Midazolam was a candidate for injection because it is rapidly absorbed from muscle. Lorazepam must be given by IV. The study found that 73 percent of patients in the group receiving midazolam via autoinjector were seizure-free upon arrival at the hospital, compared to 63 percent of patients who received IV treatment with lorazepam.

Patients treated with midazolam were also less likely to require hospitalization than those receiving IV lorazepam. Among those admitted, both groups had similarly low rates of recurrent seizures.

"Any seizure a patient suffers is a serious medical situation, but seizures that continue more than five minutes are particularly dangerous. We are extremely excited about the results of this study, which will give medical providers and potentially others such as family members of seizure patients a rapid and effective new treatment option to stop dangerous seizures that are not stopping on their own," said Dr. Roger Humphries, chair of the UK Department of Emergency Medicine and principal investigator of the study's UK site.

"Patients with status epilepticus can suffer severe consequences if seizures are not stopped quickly. This study establishes that rapid intramuscular injection of an anticonvulsant drug is safe and effective," said Dr. Walter Koroshetz, deputy director of the National Institute of Neurological Disorders and Stroke (NINDS), part of the NIH, which funded the study.

The investigators said that while autoinjectors might someday be available for use by epilepsy patients and their family members, more research is required. Because of the strong sedative effect of midazolam, on-site medical supervision is now required for the safety of the patient.


'/>"/>

Contact: Allison Elliott
allison.elliott@uky.edu
University of Kentucky
Source:Eurekalert

Related medicine news :

1. Arsenic Might Be Found in Some Organic Foods: Study
2. Study Finds Gene Behind Inherited Cases of Enlarged Heart
3. Ending individual mandate would not dramatically hike insurance prices, study finds
4. Parent-training intervention curbs pediatric obesity rates, study shows
5. Autoinjector Offers Safe, Speedy Care for Life-Threatening Seizures: Study
6. Weekend Delivery Doesnt Hurt Babies With Birth Defects: Study
7. Millions of Americans Have Untreated Hearing Loss: Study
8. Autism affects motor skills, study indicates
9. Antibiotics Dont Help Most Sinus Infections, Study Finds
10. Any Exercise Benefits Kids Heart Health: Study
11. Teens With Autism Preoccupied With TV, Video Games: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Greifensee, Switzerland (PRWEB) , ... December 06, 2016 ... ... Library, a one-stop portal for all the knowledge resources, including white papers, ... instructions, certificates, and more. , To access more than 9,000 documents, webinars ...
(Date:12/6/2016)... ... ... 'Tis the season for family, festivity, food and fun! Temptation abounds, and ... eating healthy, staying active, and taking medication and doing daily foot health checks (a ... "Shopping trips, parties and family gatherings can take their toll on our feet during ...
(Date:12/6/2016)... ... December 06, 2016 , ... Specialty ... newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol for Great ... understand the scope of their EHS regulatory obligations and rapidly collect, share, archive, ...
(Date:12/6/2016)... Aliso Viejo, California (PRWEB) , ... December 06, 2016 , ... ... which allows users to flicker, flash, and flare from clip to clip with high ... , TransFlare 4K Jewel contains 44 lens flares filmed on the RED ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is a tool that ... without heavy rendering or complicated compositing," said Christina Austin - CEO of Pixel Film ... organic spectrum of lights that simulates the look of a glare. Just drag ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016 Eurofins ... accreditation from the College of American Pathologists (CAP) ... (CLIA) for its new laboratory in ... moved its North American headquarters. "Our ... sequencing -- which is still considered the ,Gold ...
(Date:12/6/2016)... Miss. , Dec. 6, 2016 Two ... rescue personnel in a simulated mass casualty event Tuesday ... . The technology debuted before an audience including ... and representatives from Homeland Security, Federal Law Enforcement ... Drone Project, known as HiRO (Health Integrated Rescue Operations), ...
(Date:12/6/2016)...  Arcturus Therapeutics, Inc. ("Arcturus" or the "Company"), ... it entered into collaboration with Takeda Pharmaceutical Company ... of NASH and other gastrointestinal (GI) related disorders, ... UNA Oligomer chemistry. The financial terms were not ... and expertise in GI disorders, we are confident ...
Breaking Medicine Technology: